Analyst Viewpoint
Increase in prevalence of osteoporosis and arthritis is a key factor augmenting the bovine-based collagen for biomedical applications market size. Bovine-based collagen helps in repairing damaged and worn out bones and cartilages.
With the help of amino acids, bovine-based collagen also facilitates restoration of the skin’s health and moisture-rich content, thereby rendering proper skin regeneration. Rise in demand for regeneration of skin cells is also boosting market progress.
High incidence of chronic diseases is prompting key market participants to expand their production of bovine-based collagen and help expedite the process of bone drafting. In turn, this is driving the bovine-based collagen for biomedical applications industry revenue.
Leading players operating in the global bovine-based collagen for biomedical applications market are carrying out technological advancements in regenerative medicines to increase their industry share.
Collagen is found in connective tissues and skin of mammals. Prominent sources of collagen include bovine, porcine, chicken, and marine animals. Bovine-based collagen aids in regeneration of skin cells and treatment of bone-related disorders.
Growth in R&D activities in terms of regenerative medicines and wound healing is a major factor responsible for the bovine-based collagen for biomedical applications market growth.
There has been a rise in usage of bovine collagen scaffolds for regenerative medicine research. A scaffold helps provide structural integrity. It also guides the restructuring process that involves donor cells’ proliferation along with growth of the host tissue. Furthermore, it helps maintain distance between the parenchymal cells.
Bovine collagen hydrogels for 3D cell culture in biotechnology comprise natural polymers (type I, in particular). They are used as hemostatic agents in the treatment of tissue injuries.
Vascular transplantation is one of the effective treatments for cardiovascular ailments. Bovine collagen coatings for cardiovascular implants are extracellular matrix (ECM) coatings that have better biocompatibility, which give the cardiovascular biomaterials a wider functional surface.
The bovine-based collagen for biomedical applications market forecast appears promising, owing to the increase in adoption of advanced wound healing products, governmental support for research in the field of biomedical applications, and technological progress in regenerative medicine.
A sizable percentage of the global population (more than 25%) is affected by arthritis and osteoporosis. Bovine-based collagen acts as a glue. In other words, it helps in extending support to the connective tissues, including bones, skin, ligaments, tendons, and cartilage that provide protection to joints.
Bovine collagen peptides for nutritional supplements, also known as collagen hydrolysate or collagen peptides, are simple to absorb. They are generally consumed in powdered form and soluble in liquids such as coffee and smoothies.
A one-year randomized controlled trial of over 100 postmenopausal women with lower bone mineral density (BMD) indicated that the intake of 5 grams of collagen peptides/day noticeably increased BMD in upper thigh and spine in comparison with placebo. This results in regularizing blood pressure.
As per the National Institutes of Health, more than 200 million people worldwide are battling osteoporosis. Furthermore, as per International Osteoporosis Foundation, 33% of women and 20% of men aged 50 and above will be afflicted with osteoporosis fractures in their lives. These figures are likely to drive the bovine-based collagen for biomedical applications market statistics in the next few years.
Bio-collagen from cattle, also known as bovine-based collagen, improves skin health. Aging results in declination of the body’s production of collagen. This, in turn, leads to withering of the skin tone.
Bovine-derived tissue repair materials help in regeneration of skin cells, thereby imparting a young and fresh look to the skin. Bovine-based collagen possesses certain essential amino acids, namely proline and glycine, which help in improving the elasticity of skin, thereby enhancing its overall texture.
Currently, majority of the populace, especially in developed regions, is not averse to trying out skin or hair products that make them look younger. Celebrities are also endorsing products that make the skin look younger on various print as well as social media platforms.
These endorsements explain the ingredients of these products, wherein bovine-based collagen is at the forefront. Continued influence of these advertisements is accelerating the bovine-based collagen for biomedical applications industry.
North America accounted for the largest bovine-based collagen for biomedical applications market share in 2022. The region is projected to maintain its dominance during the forecast period.
High market share of North America can be ascribed to the growth in incidence of bone-related ailments in the U.S. and Canada.
As per Statistics Canada’s August 2022 update, 657,900 individuals aged between 35 and 49, 3,138,500 people aged 65 and above, and 2,042,100 people aged between 50 and 64 were suffering from arthritis in 2021.
High incidence of acute and chronic wounds is also boosting market expansion in North America. According to Mission Regional Medical Center’s 2022 update, 6.7 million individuals were suffering from chronic wounds and the number is likely to increase by more than 2.0% between 2022 and 2032. It further states that the U.S. is home to over 29 million people with diabetes, with almost 2 million of them likely to develop diabetic foot ulcer/non-healing wound every year.
Companies operating in the global bovine-based collagen for biomedical applications landscape are engaged in launching new lines of products to strengthen their market position. They are also devising collagen-like powders to cater to the increasing demand for biocompatible bovine collagen.
In June 2022, Jellatech announced that it had developed cultivated collagen that is bio-identical to collagen naturally occurring in animals. The company claims that it can be used in cosmetics, medicine, and food industries.
BBI Solutions, Symatese, Gurnet Point Capital, Viscofan BioEngineering, Collagen Solutions LLP, Botiss Biomaterials GmbH, Medtronic, KYERON, and Collagen Matrix, Inc. are the leading bovine-based collagen for biomedical applications market manufacturers.
These firms have been profiled in the bovine-based collagen for biomedical applications market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 1.1 Bn |
| Market Forecast (Value) in 2031 | US$ 2.5 Bn |
| Market Growth Rate (CAGR) | 9.7% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.1 Bn in 2022
It is projected to advance at a CAGR of 9.7% from 2023 to 2031
Increase in prevalence of osteoporosis and arthritis, and growth in demand for regeneration of skin cells
The bone graft substitutes segment accounted for the largest share in 2022
North America was the dominant region in 2022
BBI Solutions, Symatese, Gurnet Point Capital, Viscofan BioEngineering, Collagen Solutions LLP, Botiss Biomaterials GmbH, Medtronic, KYERON, and Collagen Matrix, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bovine-based Collagen for Biomedical Applications Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2017–2031
6.3.1. Bone Graft Substitutes
6.3.2. Cartilage Repairs
6.3.3. Collagen-based Scaffolds
6.3.4. Hemostats
6.3.5. Skin Substitutes
6.3.6. Wound Dressings
6.3.7. Others
6.4. Market Attractiveness Analysis, by Application
7. Global Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region, 2017–2031
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast
8.1. Introduction
8.2. Key Findings
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Bone Graft Substitutes
8.3.2. Cartilage Repairs
8.3.3. Collagen-based Scaffolds
8.3.4. Hemostats
8.3.5. Skin Substitutes
8.3.6. Wound Dressings
8.3.7. Others
8.4. Market Value Forecast, by Country, 2017–2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Application
8.5.2. By Country
9. Europe Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast
9.1. Introduction
9.2. Key Findings
9.3. Market Value Forecast, by Application, 2017–2031
9.3.1. Bone Graft Substitutes
9.3.2. Cartilage Repairs
9.3.3. Collagen-based Scaffolds
9.3.4. Hemostats
9.3.5. Skin Substitutes
9.3.6. Wound Dressings
9.3.7. Others
9.4. Market Value Forecast, by Country/Sub-region, 2017–2031
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By Country/Sub-region
10. Asia Pacific Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Bone Graft Substitutes
10.3.2. Cartilage Repairs
10.3.3. Collagen-based Scaffolds
10.3.4. Hemostats
10.3.5. Skin Substitutes
10.3.6. Wound Dressings
10.3.7. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By Country/Sub-region
11. Latin America Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Bone Graft Substitutes
11.3.2. Cartilage Repairs
11.3.3. Collagen-based Scaffolds
11.3.4. Hemostats
11.3.5. Skin Substitutes
11.3.6. Wound Dressings
11.3.7. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By Country/Sub-region
12. Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Bone Graft Substitutes
12.3.2. Cartilage Repairs
12.3.3. Collagen-based Scaffolds
12.3.4. Hemostats
12.3.5. Skin Substitutes
12.3.6. Wound Dressings
12.3.7. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East & Africa
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
13.2. Market Share Analysis, by Company (2022)
13.3. Company Profiles
13.3.1. BBI Solutions
13.3.1.1. Company Overview
13.3.1.2. Product Portfolio
13.3.1.3. SWOT Analysis
13.3.1.4. Financial Overview
13.3.1.5. Strategic Overview
13.3.2. Symatese
13.3.2.1. Company Overview
13.3.2.2. Product Portfolio
13.3.2.3. SWOT Analysis
13.3.2.4. Financial Overview
13.3.2.5. Strategic Overview
13.3.3. Gurnet Point Capital
13.3.3.1. Company Overview
13.3.3.2. Product Portfolio
13.3.3.3. SWOT Analysis
13.3.3.4. Financial Overview
13.3.3.5. Strategic Overview
13.3.4. Viscofan BioEngineering (a part of Naturin Viscofan GmbH)
13.3.4.1. Company Overview
13.3.4.2. Product Portfolio
13.3.4.3. SWOT Analysis
13.3.4.4. Financial Overview
13.3.4.5. Strategic Overview
13.3.5. Collagen Solutions LLP
13.3.5.1. Company Overview
13.3.5.2. Product Portfolio
13.3.5.3. SWOT Analysis
13.3.5.4. Financial Overview
13.3.5.5. Strategic Overview
13.3.6. Botiss Biomaterials GmbH
13.3.6.1. Company Overview
13.3.6.2. Product Portfolio
13.3.6.3. SWOT Analysis
13.3.6.4. Financial Overview
13.3.6.5. Strategic Overview
13.3.7. Medtronic
13.3.7.1. Company Overview
13.3.7.2. Product Portfolio
13.3.7.3. SWOT Analysis
13.3.7.4. Financial Overview
13.3.7.5. Strategic Overview
13.3.8. Taxus Cardium
13.3.8.1. Company Overview
13.3.8.2. Product Portfolio
13.3.8.3. SWOT Analysis
13.3.8.4. Financial Overview
13.3.8.5. Strategic Overview
13.3.9. KYERON
13.3.9.1. Company Overview
13.3.9.2. Product Portfolio
13.3.9.3. SWOT Analysis
13.3.9.4. Financial Overview
13.3.9.5. Strategic Overview
13.3.10. Collagen Matrix, Inc.
13.3.10.1. Company Overview
13.3.10.2. Product Portfolio
13.3.10.3. SWOT Analysis
13.3.10.4. Financial Overview
13.3.10.5. Strategic Overview
List of Tables
Table 01: Global Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 02: Global Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 03: North America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 04: North America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 05: Europe Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 06: Europe Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 07: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 09: Latin America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 10: Latin America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application 2022–2031
Figure 03: Global Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 04: Global Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Region, 2022–2031
Figure 05: Global Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Region, 2023–2031
Figure 06: North America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 07: North America Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application, 2022–2031
Figure 08: North America Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 09: North America Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Country, 2022–2031
Figure 10: North America Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Country, 2023–2031
Figure 11: Europe Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 12: Europe Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application, 2022–2031
Figure 13: Europe Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 14: Europe Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 15: Europe Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 16: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 17: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application 2022–2031
Figure 18: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 19: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 20: Asia Pacific Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 21: Latin America Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 22: Latin America Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application, 2022–2031
Figure 23: Latin America Africa Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 24: Latin America Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 25: Latin America Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 26: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Value (US$ Mn) Forecast, 2017–2031
Figure 27: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Application, 2022–2031
Figure 28: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Application, 2023–2031
Figure 29: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Middle East & Africa Bovine-based Collagen for Biomedical Applications Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 31: Global Africa Bovine-based Collagen for Biomedical Applications Market Share Analysis, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Bovine-based Collagen for Biomedical Applications Market
